Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 116

1.

Lung-limited granulomatosis with polyangiitis: managed without immunosuppression.

Iau Graca Ribeiro LM, Ind PW.

QJM. 2019 Sep 1;112(9):685-688. doi: 10.1093/qjmed/hcz131. No abstract available.

PMID:
31147704
2.

Marijuana and the lung: hysteria or cause for concern?

Ribeiro L, Ind PW.

Breathe (Sheff). 2018 Sep;14(3):196-205. doi: 10.1183/20734735.020418.

3.

A randomised, double-blind, placebo-controlled study to evaluate the efficacy of oral azithromycin as a supplement to standard care for adult patients with acute exacerbations of asthma (the AZALEA trial).

Johnston SL, Szigeti M, Cross M, Brightling C, Chaudhuri R, Harrison T, Mansur A, Robison L, Sattar Z, Jackson D, Mallia P, Wong E, Corrigan C, Higgins B, Ind P, Singh D, Thomson N, Ashby D, Chauhan A.

Southampton (UK): NIHR Journals Library; 2016 Oct.

4.

Effect of cannabis smoking on lung function and respiratory symptoms: a structured literature review.

Ribeiro LI, Ind PW.

NPJ Prim Care Respir Med. 2016 Oct 20;26:16071. doi: 10.1038/npjpcrm.2016.71. Review.

5.

Azithromycin for Acute Exacerbations of Asthma : The AZALEA Randomized Clinical Trial.

Johnston SL, Szigeti M, Cross M, Brightling C, Chaudhuri R, Harrison T, Mansur A, Robison L, Sattar Z, Jackson D, Mallia P, Wong E, Corrigan C, Higgins B, Ind P, Singh D, Thomson NC, Ashby D, Chauhan A; AZALEA Trial Team.

JAMA Intern Med. 2016 Nov 1;176(11):1630-1637. doi: 10.1001/jamainternmed.2016.5664. Erratum in: JAMA Intern Med. 2018 Jul 1;178(7):1003.

6.

Occam's razor or Hickam's dictum? Allergic bronchopulmonary aspergillosis and eosinophilic granulomatosis with polyangiitis.

Henderson SR, Shah A, Copley SJ, Cook HT, Pusey CD, Salama AD, Ind PW.

Thorax. 2016 Feb;71(2):193-5. doi: 10.1136/thoraxjnl-2015-207280. Epub 2015 Dec 23. No abstract available.

7.

Prolonged B cell depletion with rituximab is effective in treating refractory pulmonary granulomatous inflammation in granulomatosis with polyangiitis (GPA).

Henderson SR, Copley SJ, Pusey CD, Ind PW, Salama AD.

Medicine (Baltimore). 2014 Dec;93(27):e229. doi: 10.1097/MD.0000000000000229.

8.

Microbial contamination of domiciliary nebulisers and clinical implications in chronic obstructive pulmonary disease.

Jarvis S, Ind PW, Thomas C, Goonesekera S, Haffenden R, Abdolrasouli A, Fiorentino F, Shiner RJ.

BMJ Open Respir Res. 2014 Feb 27;1(1):e000018. doi: 10.1136/bmjresp-2013-000018. eCollection 2014.

9.

An undiagnosed stupor in the acute medical unit: a case of malignant catatonia.

Adams G, Brown A, Burnside A, Tanday R, Lowe D, Li K, Malhotra PA, Falinska A, Coker R, Ind P, Waheed U, Broomhead R, Bassett JH, Sam AH.

QJM. 2015 Apr;108(4):335-6. doi: 10.1093/qjmed/hcu118. Epub 2014 May 26. No abstract available.

PMID:
24865260
10.

Reply to the editor.

Al Jaaly E, Fiorentino F, Reeves BC, Ind PW, Angelini GD, Kemp S, Shiner RJ.

J Thorac Cardiovasc Surg. 2013 Nov;146(5):1299-300. doi: 10.1016/j.jtcvs.2013.07.004. No abstract available.

11.

Effect of adding postoperative noninvasive ventilation to usual care to prevent pulmonary complications in patients undergoing coronary artery bypass grafting: a randomized controlled trial.

Al Jaaly E, Fiorentino F, Reeves BC, Ind PW, Angelini GD, Kemp S, Shiner RJ.

J Thorac Cardiovasc Surg. 2013 Oct;146(4):912-8. doi: 10.1016/j.jtcvs.2013.03.014. Epub 2013 Apr 11.

12.

Tobacco industry lobbyists and their health-care clients.

Hopkinson NS, Moxham J, Montgomery H, West R, Scally G, McKee M, Spiro S, Bush A, Stradling J, Wells A, Chung KF, Durham SR, Martin FC, Congleton J, Roddy E, Dayer M, White P, Ind PW, Brown JL, Patel I, Lewis K, Hart N, Kemp S, Barker J, Hind M, Nicholl D, Stern M, Elkin S.

Lancet. 2013 Feb 9;381(9865):445. doi: 10.1016/S0140-6736(13)60236-6. No abstract available.

PMID:
23399061
13.

Pulmonary-renal syndrome: a life threatening but treatable condition.

West SC, Arulkumaran N, Ind PW, Pusey CD.

Postgrad Med J. 2013 May;89(1051):274-83. doi: 10.1136/postgradmedj-2012-131416. Epub 2013 Jan 24. Review.

PMID:
23349383
14.

Diffuse alveolar haemorrhage in ANCA-associated vasculitis.

West S, Arulkumaran N, Ind PW, Pusey CD.

Intern Med. 2013;52(1):5-13. Epub 2013 Jan 1. Review.

15.

Relation between trunk fat volume and reduction of total lung capacity in obese men.

Watson RA, Pride NB, Thomas EL, Ind PW, Bell JD.

J Appl Physiol (1985). 2012 Jan;112(1):118-26. doi: 10.1152/japplphysiol.00217.2011. Epub 2011 Sep 22.

16.

Interstitial lung disease and ANCA-associated vasculitis: a retrospective observational cohort study.

Arulkumaran N, Periselneris N, Gaskin G, Strickland N, Ind PW, Pusey CD, Salama AD.

Rheumatology (Oxford). 2011 Nov;50(11):2035-43. doi: 10.1093/rheumatology/ker236. Epub 2011 Aug 25.

PMID:
21873269
17.

Mucormycosis may mimic disease relapse in Wegener's granulomatosis.

Nogueira EL, Ind PW, Friedland JS, Salama AD.

J Rheumatol. 2010 Jun;37(6):1364-5. doi: 10.3899/jrheum.091423. No abstract available.

PMID:
20516047
18.

Reduction of total lung capacity in obese men: comparison of total intrathoracic and gas volumes.

Watson RA, Pride NB, Thomas EL, Fitzpatrick J, Durighel G, McCarthy J, Morin SX, Ind PW, Bell JD.

J Appl Physiol (1985). 2010 Jun;108(6):1605-12. doi: 10.1152/japplphysiol.01267.2009. Epub 2010 Mar 18.

19.

Similar efficacy of ciclesonide versus prednisolone to treat asthma worsening after steroid tapering.

van den Berge M, Arshad SH, Ind PW, Magnussen H, Hamelmann E, Kanniess F, Postma DS.

Respir Med. 2009 Aug;103(8):1216-23. doi: 10.1016/j.rmed.2009.01.024. Epub 2009 Mar 18.

20.

Wegener's granulomatosis presenting as acute systemic vasculitis following 20 years of limited tracheobronchial disease.

Peters JE, Salama AD, Ind PW.

J Laryngol Otol. 2009 Dec;123(12):1375-7. doi: 10.1017/S002221510900454X. Epub 2009 Jan 28. Review.

PMID:
19175952
21.

Dendritic cells from control but not atopic donors respond to contact and respiratory sensitizer treatment in vitro with differential cytokine production and altered stimulatory capacity.

Holden NJ, Bedford PA, McCarthy NE, Marks NA, Ind PW, Jowsey IR, Basketter DA, Knight SC.

Clin Exp Allergy. 2008 Jul;38(7):1148-59. doi: 10.1111/j.1365-2222.2008.02997.x. Epub 2008 May 21.

PMID:
18498417
22.

A 9-yr evaluation of carrier erythrocyte encapsulated adenosine deaminase (ADA) therapy in a patient with adult-type ADA deficiency.

Bax BE, Bain MD, Fairbanks LD, Webster AD, Ind PW, Hershfield MS, Chalmers RA.

Eur J Haematol. 2007 Oct;79(4):338-48. Epub 2007 Aug 3.

PMID:
17680812
23.
24.

Results of endoscopic surgery and intralesional steroid therapy for airway compromise due to tracheobronchial Wegener's granulomatosis.

Nouraei SA, Obholzer R, Ind PW, Salama AD, Pusey CD, Porter F, Howard DJ, Sandhu GS.

Thorax. 2008 Jan;63(1):49-52. Epub 2007 Jun 15.

PMID:
17573443
25.

Inhaled therapy in elderly COPD patients; time for re-evaluation?

Jarvis S, Ind PW, Shiner RJ.

Age Ageing. 2007 Mar;36(2):213-8. Epub 2007 Jan 31.

PMID:
17267450
26.

Inhaled allergen-driven CD1c up-regulation and enhanced antigen uptake by activated human respiratory-tract dendritic cells in atopic asthma.

McCarthy NE, Jones HA, Marks NA, Shiner RJ, Ind PW, Al-Hassi HO, English NR, Murray CM, Lambert JR, Knight SC, Stagg AJ.

Clin Exp Allergy. 2007 Jan;37(1):72-82.

PMID:
17210044
27.

Concurrent therapy (long acting beta agonists and inhaled corticosteroids) in the management of asthma.

Saleh JA, Ind PW.

Niger J Med. 2006 Oct-Dec;15(4):359-63. Review.

PMID:
17111718
28.

Once daily inhaled steroids for asthma: how useful are pharmaco-economic data?

Ind P.

Prim Care Respir J. 2005 Apr;14(2):62-4. Epub 2005 Mar 3. No abstract available.

29.

COPD disease progression and airway inflammation: uncoupled by smoking cessation.

Ind PW.

Eur Respir J. 2005 Nov;26(5):764-6. No abstract available.

30.

Bigger may be better: targeted beta2-agonist therapy.

Ind PW.

Am J Respir Crit Care Med. 2005 Sep 15;172(6):656-7. No abstract available. Erratum in: Am J Respir Crit Care Med. 2005 Dec 15;172(12):1605.

PMID:
16148193
31.
32.

Peripheral pulmonary artery pseudoaneurysms and massive hemoptysis.

Sbano H, Mitchell AW, Ind PW, Jackson JE.

AJR Am J Roentgenol. 2005 Apr;184(4):1253-9.

PMID:
15788606
33.

Adjustable and fixed dosing with budesonide/ formoterol via a single inhaler in asthma patients: the ASSURE study.

Ind PW, Haughney J, Price D, Rosen JP, Kennelly J.

Respir Med. 2004 May;98(5):464-75.

34.

Images in Thorax. Crack inhalation induced pneumomediastinum.

Janes SM, Ind PW, Jackson J.

Thorax. 2004 Apr;59(4):360. No abstract available.

35.

The effect of the steroid-sparing response to low-dose methotrexate on bone metabolism in glucocorticoid-dependent asthmatics.

Girgis SI, Nwokeji A, Shakur BH, Ind PW, Shiner RJ.

Clin Chim Acta. 2004 Mar;341(1-2):157-63.

PMID:
14967172
36.

Methotrexate therapy in asthma increases T cell susceptibility to corticosteroid inhibition.

Corrigan CJ, Shiner R, Shakur BH, Ind PW.

Clin Exp Allergy. 2003 Aug;33(8):1090-6.

PMID:
12911783
37.

Addition of salmeterol to fluticasone propionate treatment in moderate-to-severe asthma.

Ind PW, Dal Negro R, Colman NC, Fletcher CP, Browning D, James MH.

Respir Med. 2003 May;97(5):555-62.

38.
39.

Safety of formoterol by Turbuhaler as reliever medication compared with terbutaline in moderate asthma.

Ind PW, Villasante C, Shiner RJ, Pietinalho A, Böszörményi NG, Soliman S, Selroos O.

Eur Respir J. 2002 Oct;20(4):859-66.

40.

Sputum induction.

Paggiaro PL, Chanez P, Holz O, Ind PW, Djukanović R, Maestrelli P, Sterk PJ.

Eur Respir J Suppl. 2002 Sep;37:3s-8s. Review. No abstract available.

41.

Inhaled corticosteroids versus anti-leukotrienes: a literature review on the clinical effects.

Ind PW.

Allergy. 1999;54 Suppl 50:43-6. Review. No abstract available.

PMID:
10466037
42.

Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society.

Chung KF, Godard P, Adelroth E, Ayres J, Barnes N, Barnes P, Bel E, Burney P, Chanez P, Connett G, Corrigan C, de Blic J, Fabbri L, Holgate ST, Ind P, Joos G, Kerstjens H, Leuenberger P, Lofdahl CG, McKenzie S, Magnussen H, Postma D, Saetta M, Salmeron S, Sterk P.

Eur Respir J. 1999 May;13(5):1198-208. Review. No abstract available.

43.

Nebulized glyceryl trinitrate exerts acute bronchodilator effects in patients with acute bronchial asthma.

Sharara AM, Hijazi M, Tarawneh M, Ind PW.

Pulm Pharmacol Ther. 1998 Feb;11(1):65-70.

PMID:
9802965
44.

Bronchoalveolar lavage causes decrease in PaO2, increase in (A-a) gradient value and bronchoconstriction in asthmatics.

Spanevello A, Migliori GB, Satta A, Sharara A, Ballardini L, Ind PW, Neri M.

Respir Med. 1998 Feb;92(2):191-7.

45.

Methods for sputum induction and analysis of induced sputum: a method for assessing airway inflammation in asthma.

Kips JC, Fahy JV, Hargreave FE, Ind PW, in't Veen JC.

Eur Respir J Suppl. 1998 Mar;26:9S-12S. Review. No abstract available.

PMID:
9585872
46.

Circadian rhythm of cutaneous hypersensitivity reactions in nocturnal asthma.

Seery JP, Janes SM, Ind PW, Datta AK.

Ann Allergy Asthma Immunol. 1998 Apr;80(4):329-32.

PMID:
9564983
47.

Dose equivalence and bronchoprotective effects of salmeterol and salbutamol in asthma.

Higham MA, Sharara AM, Wilson P, Jenkins RJ, Glendenning GA, Ind PW.

Thorax. 1997 Nov;52(11):975-80.

48.

Comparison of two methods of processing induced sputum: selected versus entire sputum.

Spanevello A, Beghé B, Bianchi A, Migliori GB, Ambrosetti M, Neri M, Ind PW.

Am J Respir Crit Care Med. 1998 Feb;157(2):665-8.

PMID:
9476888
49.
50.

Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma.

Crimi E, Spanevello A, Neri M, Ind PW, Rossi GA, Brusasco V.

Am J Respir Crit Care Med. 1998 Jan;157(1):4-9.

PMID:
9445270

Supplemental Content

Support Center